77613-65-1 Usage
Uses
Used in Pharmaceutical Industry:
1-BROMOMETHYL-2,2-DIFLUOROCYCLOPROPANE is used as a key intermediate in the synthesis of pharmaceuticals for its ability to facilitate the creation of complex molecular structures and enhance the properties of drug molecules.
Used in Agrochemical Industry:
In the agrochemical sector, 1-BROMOMETHYL-2,2-DIFLUOROCYCLOPROPANE is employed as a precursor in the production of agrochemicals, contributing to the development of effective and innovative products for agricultural applications.
Used in Material Science:
1-BROMOMETHYL-2,2-DIFLUOROCYCLOPROPANE is utilized as a component in the development of new materials, leveraging its unique chemical properties to create novel substances with specific characteristics for various applications.
Used in Chemical Process Development:
1-BROMOMETHYL-2,2-DIFLUOROCYCLOPROPANE is used as a reactant in the development of new chemical processes, where its reactivity and potential for novel reactions are harnessed to improve existing methods or create new pathways for chemical synthesis.
It is important to handle 1-BROMOMETHYL-2,2-DIFLUOROCYCLOPROPANE with caution due to its potential hazards and reactivity, ensuring that safety measures are in place during its use in research, production, and other applications.
Check Digit Verification of cas no
The CAS Registry Mumber 77613-65-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,6,1 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 77613-65:
(7*7)+(6*7)+(5*6)+(4*1)+(3*3)+(2*6)+(1*5)=151
151 % 10 = 1
So 77613-65-1 is a valid CAS Registry Number.
77613-65-1Relevant academic research and scientific papers
IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS
-
, (2022/03/31)
This invention relates to Imidazo[1,2-a]pyridinyl Derivatives of formula (I′), or pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, capable of modulating the activity of IRAK4. The invention further provides a method of manufacturing compounds of the invention, and methods for their therapeutic use. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including inflammatory disease, autoimmune disease, cancer, cardiovascular disease, a disease of the central nervous system, disease of the skin, an ophthalmic disease and condition, and a bone disease.
